Andrew M. Beato Partner
Andrew M. Beato is the Chair of the False Claims Act and Whistleblower Practice Group at Stein Mitchell Cipollone Beato & Missner LLP. His practice focuses on representing qui tam relators in the United States and abroad in cases involving violations of the False Claims Act. Mr. Beato has substantial experience representing clients in high-profile government fraud investigations with various state and federal agencies, including the Department of Justice, State Attorneys General Offices, the Food and Drug Administration, the U.S. Department of Health and Human Services, the Centers for Medicare and Medicaid Services, the Securities and Exchange Commission, the Internal Revenue Service, and the Department of Defense. In addition, he represents clients in regulatory matters before the Federal Trade Commission, the Federal Communications Commission, and state agencies.
In an article published in The Hindu, India’s leading English language newspaper, Mr. Beato advocates for a strong whistle-blower protection law: No country for whistle-blowers.
Honors & Awards
WASHINGTON’S BEST LAWYERS 2016, 2015, 2013
- WASHINGTONIAN Magazine selects Andrew Beato for his outstanding record of achievement as a Whistleblower lawyer.
Community & Professional Activities
Member, American Bar Association, Antitrust Section
Member, Maryland State Bar Association
Member, District of Columbia Bar Association
Worth the price? Push for cheaper generic drugs has Canadians buying questionable medicines from IndiaWhistleblower represented by Andrew Beato uncovers questionable manufacturing standards, manipulated records and defective drugs at Ranbaxy LaboratoriesOriginally Published in The National Post
Andrew Beato cited in article that states, "It is not the responsibility of the government alone to act in order to curb corruption; corporate firms need to be proactive as well in checking fraudulent financial practices"Originally Published in The Hindu
Bloomberg article quotes Andrew Beato, "There’s a pattern of conduct at other companies that are similar, if not identical, to the Ranbaxy problems"Originally Published in Bloomberg Business
Whistleblower Dinesh Thakur's attorney, Andrew Beato, says Ranbaxy suit has sparked increase in violation reports due to raised awareness of the False Claims ActOriginally Published in The Economic Times
The firm announces a name change to Stein Mitchell Muse Cipollone & Beato LLP, recognizing the strategic leadership and exceptional contribution of partner, Andrew M. BeatoPress Release
Stein Mitchell Muse Cipollone & Beato LLP Announces $16.5 Million False Claims Act Settlement for Unnecessary Heart Procedures Performed by St. Joseph Health SystemKentucky Hospital Settles Allegations that Physicians Performed Unnecessary Open-Heart Procedures and Maintained Improper Financial Relationships with Physicians in Violation of Kickback and Stark LawsPress Release
Four Stein Mitchell Muse Cipollone & Beato LLP Attorneys Named to Elite List of “Best Lawyers” by WASHINGTONIAN MagazinePress Release
Correspondent John Miller interviews Ranbaxy whistleblower Dinesh Thakur represented by Washington D.C. Attorneys Andrew Beato and Bob MusePress Release
Author, Newly Independent and Separating States' Succession to Treaties, 9 Am. U.J. Int'l & Pol'y 525 (1994).
Co-author, The Law of Law Firms (West) (2d ed. 2012).
Chapter Co-author, ABA Consumer Law Developments
- District of Columbia
- Fourth Circuit Court of Appeals
American University, The Washington College of Law, J.D.
- Staff editor, The American University Journal of International Law and Policy
Boston University, 1991, summa cum laude with distinction